31
Views
20
CrossRef citations to date
0
Altmetric
Review

Inducible nitric oxide synthase and inflammation

&
Pages 65-75 | Published online: 23 Feb 2005

Bibliography

  • GRIFFITH OW, STUEHR DJ: Nitric oxide synthases:properties and catalytic mechanism. In: Ann. Rev. PhysioL Hoffman JF, De Weer P (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 57:707–736.
  • FORSTERMANN U, CLOSS El, POLLOCK JS et al.: Nitric ox-ide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension (1995) 23:1121–1131.
  • KNOWLES RG, MONCADA S: Nitric oxide synthases inmammals. Biochem. J. (1994) 298:249–258.
  • MONCADA S, HIGGS A: The L-arginine-nitric oxide pathway. New Engl. J. Med. (1993) 329:2002–2012.
  • NATHAN C: Nitric oxide as a secretory product of mam-malian cells. FASEB (1992) 6:3051–3064.
  • STUEHR DJ, KWON NS, NATHAN CF et al.: N-hydroxy-L-a-rginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. (1991) 266:6259–6263.
  • WALLACE GC, FUKOTO JM: Synthesis and bioactivity ofN-hydroxyarginine; a possible intermediate in the bio-synthesis of nitric oxide from arginine. J. Med, Chem. (1993) 34:1746–1748.
  • IGNARRO LJ, FUKOTO JM, GRISCAVAGE JM, ROGERS NE, BYRNS RE: Oxidation of nitric oxide in aqueous solu-tions to nitrite but not nitrate; comparison with enzy-matically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci, USA (1993) 90:8103–8107.
  • JANSSENS SP, SHIMOUCHI A, QUERTERMOUS T, BLOCH DB, BLOCH KD: Cloning and expression of a cDNA en-coding human endothelium-derived relaxing fac-tor/nitric oxide synthase. J. Biol. Chem. (1992) 267:14519–14522.
  • MARSDEN PA, SCHAPPERT KT, CHEN HS et al.: Molecular cloning and characterization of human endothelial ni-tric oxide synthase. FEBS Lett. (1992) 207:287–293.
  • SCHMIDT HHHW, MURAD F: Purification and charac-terization of a human NO synthase. Biochem, Biophys, Res. Commun. (1991) 181:1372–1377.
  • NAKANE M, SCHMIDT HHHW, POLLOCK JS, FORSTER-MANN U, MURAD F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. (1993) 316:175–180.
  • GELLER DA, LOWENSTEIN CJ, SHAPIRO RA et al: Molecu-lar cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci, USA (1993) 90:3491–3495.
  • SHERMAN PA, LAUBACH VE, REEP BR, WOOD ER: Purifi-cation and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry (1993) 32:11600–11605.
  • CHARLES IG, PALMER RMJ, HICKERY MS et al.: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc. Natl. Acad. Sci, USA (1993) 90:11419–11423.
  • CHO HJ, XIE Q-W, CALAYCAY J et al.: Calmodulin as atightly bound subunit of calcium-, calmodulin-independent nitric oxide synthase. J. Exp. Med. (1992) 176:599–604.
  • SONNTAG M, DEUSSEN A, SCHRADER J: Role of nitric ox-ide in local blood flow control in the anaesthetized dog. Pflugers Arch. Dir. J. Physiol, (1992) 420:194–199.
  • RADOMSKI MW, PALMER RMJ, MONCADA S: An L-a-rginine/nitric oxide pathway present in human plate-lets regulates aggregation. Proc. Natl. Acad. Sci, USA (1990) 87:5193–5197.
  • KUBES P, SUZUKI M, GRANGER DN: Nitric oxide: an en-dogenous modulator of leukocyte adhesion. Proc. NatL Acad. Sci, USA (1991) 88:4651–4655.
  • NAKAKI T, NAKAYAMA M, KATO R: Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Lir. J. Phar-macoL (1990) 1898:347–353.
  • ZHANG J, SNYDER SH: Nitric oxide in the nervous sys-tem. In: Ann. Rev. Pharmacol, Toxicol, Cho AK, Blaschke TF, Loh HH, Way JL (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 35:213–233.
  • RAND MJ, LI CG: Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mecha-nism of transmission. In: Ann. Rev. Physiol. Hoffman JF, De Weer P (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 57:659–682.
  • GARTHWAITE J, BOULTON CL: Nitric oxide signaling in the central nervous system. In: Ann. Rev. PhysioL Hoff-man JF, De Weer P (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 57:683–706.
  • SCHUMAN EM, MADISON DV: Nitric oxide and synaptic function. In: Ann. Rev. Neurosci, Cowan WM, Shooter EM, Stevens CF, Thompson RF (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 17:153–183.
  • KRONCKE K-D, FEHSEL K, KOLB-BACHOFEN V: Induci-ble nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol. Chem. Hoppe-Seyler (1995) 376:327–343.
  • DENIS M: Human monocytes/macrophages: NO or no NO? J. Leuk, Biol. (1994) 55:682–684.
  • WEINBERG JB, MISUKONIS MA, SHAMI PJ et al.: Human mononuclear phagocyte inducible nitric oxide syn-thase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood mono-cytes and peritoneal macrophages. Blood (1995) 86:1184–1195.
  • STUEHR DJ, GRIFFITH OW: Mammalian nitric oxide synthases. In: Adv. Enzym, Meister A (Ed.), Wiley, New York (1992) 65:287–436.
  • MARLETTA MA: Approaches toward selective inhibi-tion of nitric oxide synthase. J. Med. Chem. (1994) 37:1899–1907.
  • FUKUTO JM, CHAUDHURI G: Inhibition of constitutiveand inducible nitric oxide synthase: potential selective inhibition. In: Ann. Rev. PharmacoL ToxicoL Cho AK, Blaschke TF, Loh HH, Way JL (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 35:165–94.
  • FREY C, NARAYANAN K, MCMILLAN K et al.: L-Thiocitru-lline. J. Biol. Chem. (1994) 269:26083–26091.
  • STUEHR DJ, FASEHUN OA, KWON NS et al.: Inhibition ofmacrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogues. FASEB J. (1991) 5:98–103.
  • BIANCHI M, ULRICH P, BLOOM O et al, An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. MoL Med. (1995) 1:254–266.
  • OLKEN NM, MARLETTA MA: NG-methyl-L-arginine func-tions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry (1993) 32:9677–9685.
  • FELDMAN PL, GRIFFITH OW, HONG H, STUEHR DJ: Irre-versible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation. J. Med. Chem. (1993) 36:491–496.
  • FURFINE ES, HARMON MF, PAITH JE, GARVEY EP: Selec-tive inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry (1993) 32:8512–8517.
  • KLATT P, SCHMIDT K, BRUNNER F, MAYER B: Inhibitorsof brain nitric oxide synthase. J. Biol. Chem. (1994) 269:1674–1680.
  • MCCALL TB, FEELISCH M, PALMER RMJ, MONCADA S: Identification of N-iminoethyl-L-ornithine as an irre-versible inhibitor of nitric oxide synthase in phago-cytic cells. Br. J. Pharmacol. (1991) 102:234–238.
  • KNOWLES RG, PALACIOS M, PALMER RMJ, MONCADA S:Kinetic characterization of nitric oxide synthase from rat brain. Biochem. J. (1990) 269:207–210.
  • REES DD, PALMER RMJ, SCHULZ R, HODSON HF, MON-CADA S: Characterization of three inhibitors of endo-thelial nitric oxide synthase in vitro and in vivo. Br. Pharmacol. (1990) 101:746–752.
  • MOORE WM, WEBBER RK, JEROME GM et al.: L-N6-(1-Iminoethyfilysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. (1994) 37:3886–3888.
  • FURFINE ES, HARMON MF, PAITH JE et al.: Potent and se-lective inhibition of human nitric oxide synthases. J. Biol. Chem. (1994) 269:26677–26683.
  • NARAYANAN K, GRIFFITH OW: Synthesis of L-thiocitru-Bine, L-homothiocitrulline, and S-methyl-L-thiocitru-Bine: a new class of potent nitric oxide synthase inhibitors. J. Med. Chem. (1994) 37:885–887.
  • NARAYANAN K, SPACK L, MCMILLAN K et al.: S-Alkyl-L--thiocitrullines. J. Biol. Chem. (1995) 270:11103–11110.
  • SZABO C, SOUTHAN GJ, THIEMERMANN C: Beneficial ef-fects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. NatL Acad. Sci. USA (1994) 91:12472–12476.
  • SOUTHAN GJ, SZABO C, THIEMERMANN C: Isothioureas:potent inhibitors of nitric oxide synthases with vari-able isoform selectivity. Br. J. Pharmacol. (1995) 114:510–516.
  • NAKANE M, KLINGHOFER V, KUK JE et al.: Novel potentand selective inhibitors of inducible nitric oxide syn-thase. MoL Pharmacol. (1995) 47:831–834.
  • GARVEY EP, OPLINGER JA, TANOURY GJ et al.: Potentand selective inhibitors of human nitric oxide syn-thases. J. Biol. Chem. (1994) 269:26669–26676.
  • NAKANE M, POLLOCK JS, KLINGHOFER V et al.: Func-tional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells. Biochem. Biophys. Res. Commun. (1995) 206:511–517.
  • CORBETT JA, TILTON RG, CHANG K et al.: Aminogua-nidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 41:552–556.
  • MISKO TP, MOORE WM, KASTEN TP et al.: Selective inhi-bition of the inducible nitric oxide synthase by ami-noguanidine. Eur. J. Pharmacol. (1993) 233:119–125.
  • WOLFF DJ, LUBESKIE A: Aminoguanidine is an isoform-selective, mechanism-based inactivator of ni-tric oxide synthase. Arch. Biochem. Biophys. (1995) 316:290–301.
  • HAMLEY P, TINKER AC: 1,2 Diaminobenzimidazoles: se-lective inhibitors of nitric oxide synthase derived from aminoguanidine. Bioorg. Med. Chem. Lett. (1995) 5:1573–1576.
  • HANSEN DW, Jr., PETERSON KB, TRIVEDI M et al. Homo- piperidines amidines as selective inhibitors of induci-ble nitric oxide synthase, endothelium. (1995) (In Press.)
  • GROSS SS: Nitric oxide: pathophysiological mecha-nisms. In: Ann. Rev. PhysioL Hoffman JF, De Weer P (Eds.), Annual Reviews, Inc., Palo Alto, CA (1995) 57:737–769.
  • MOILANEN E, VAPAATALO H: Nitric oxide in inflamma-tion and immune response. Ann. Med. (1995) 27:359–367.
  • ANGGARD E: Nitric oxide: mediator, murderer, andmedicine. Lancet (1994) 343:1199–1205.
  • NUSSLER AK, BILLIAR TR: Inflammation, immunoregu-lation, and inducible nitric oxide synthase. J. Leuk. Biol. (1993) 54:171–178.
  • CLANCY RM, ABRAMSON SB: Nitric oxide: a novel me-diator of inflammation. Soc. Exp. Biol. Med. (1995) 23:93–101.
  • MONCADA S, HIGGS EA: Molecular mechanisms andtherapeutic strategies related to nitric oxide. FASEB J. (1995) 9:1319–1330.
  • WARREN JB: Nitric oxide and human skin blood flowresponses to acetylcholine and ultraviolet light. FASEB J. (1994) 8:247–251.
  • IALENTI A, IANARO A, MONOCADA S, DI ROSA M: Modu-lation of acute inflammation by endogenous nitric ox-ide. Eur. J. Pharmacol. (1992) 211:177–182.
  • SALVEMINI D, WANG ZQ, WYATT P, MARINO MH, CURRIEMG: Roles of Inducible nitric oxide synthase in the carrageenan-induced paw model of inflammation. En-dothelium (1995) 3:205.
  • TEIXEIRA MM, WILLIAMS TJ, HELLEWELL PG: Role ofprostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. (1993) 110:1515–1521.
  • MULLIGAN MS, HEVEL JM, MARLETTA MA, WARD PA: Tis-sue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci, USA (1991) 88:6338–6342.
  • KOLB H, KOLB-BACHOFEN V: Nitric oxide: a pathogenicfactor in autoimmunity. ImmunoL Today (1992) 13:157–159.
  • STEFANOVIC-RACIC M, STADLER J, EVANS CH: Nitric ox-ide and arthritis. Arthritis Rheum. (1993) 36:1036–1044.
  • FARRELL AJ, BLAKE DR, PALMER RM, MONCADA S: In-creased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthe-sis in rheumatic diseases. Ann. Rheum. Dis, (1992) 51 :1219–1222.
  • KAUR H, HALLIWELL B: Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. FEBS Lett. (1994) 350:9–12.
  • MCCARTNEY-FRANCIS N, ALLEN JB, MIZEL DE et al.: Sup-pression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. (1993) 178:749–754.
  • WEINBERG JB, GRANGER DL, PISETSKY DS et al.: The roleof nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally adminis-tered NG-monomethyl-L-arginine. J. Exp. Med. (1994) 179:651–660.
  • STEFANOVIC-RACIC M, MEYERS K, MESCHTER C et al.: N-Monomethyl arginine, an inhibitor of nitric oxide syn-thase, suppresses the development of adjuvant arthri-tis in rats. Arthritis Rheum. (1994) 7:1062–1069.
  • CONNOR J, MANNING PT, SETTLE SL et al.: Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol, (1995) 273:15–24.
  • SALVEMINI D, SEIBERT K, MASFERRER JL et al.: Endoge-nous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Din. Invest. (1994) 93:1940–1947.
  • SALVEMINI D, SETTLE SL, MASFERRER JL eta/.: Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br. J. Pharmacol, (1995).114:1171–1178.
  • CATTELL V, COOK T, MONCADA S: Glomeruli synthe-size nitrite in experimental nephrotoxic nephritis. Kidney Int. (1990) 38:1056–1060.
  • COOK HY, SULLIVAN R: Glomerular nitrate synthesis in situ immune complex glomerulonephritis in the rat. Am. J. PathoL (1990) 139:1047–1052.
  • SALVEMINI D, MISKO TP, MASFERRER JL et al.: Nitric ox-ide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci, USA (1993) 90:7240–7244.
  • BECKMAN JS, BECKMAN TW, CHEN TW, MARSHALL PA,FREEMAN BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci, USA (1990) 87:1620–1624.
  • TSAI AL, WEI C, KULMACZ RJ: Interaction between nitric oxide and prostaglandin H synthase. Arch. Biochem, Biophys. (1994) 313:367–372.
  • HADAR DP, LANDER HM, PEARCE FS, UPMACIS RK, POM-ERANTZ KB: Nitric oxide enhances prostaglandin-H synthase activity by a haem-independent mechanism: evidence implicating nitrosothiols. J. Am. Chem. Soc. (1995) 117:3340–3346.
  • LANDINO LM, CREWS BC, TIMMONS MD, MORROW JD, MARNETT LJ: Peroxynitrite, the coupling product of ni-tric oxide and superoxide, activates prostaglandin bio-synthesis. Proc. Natl. Acad. Sci, USA (1 9 9 6) 93:15069–15074.
  • SALVEMINI D, MANNING PT, ZWEIFEL BS et al.: Dual inhi-bition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of ni-tric oxide synthase inhibitors. J. Din. Invest. (1995) 96:301–308.
  • VANE JR, MITCHELL JA, APPLETON I et al.: Inducible iso-forms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci, USA (1994) 91:2046–2050.
  • SWIERKOSZ TA, MITCHELL JA, WARNER TD, BOTTINGRM, VANE RR: Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric ox-ide and prostanoids. Br. J. PharmacoL (1995) 114:1335–1342.
  • SALVEMINI D, WANG ZQ, WYATT PS et al.: Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol, (1996) 118:829–838.
  • CORBETT JA, KWON G, TURK J, MCDANIEL ML: 11-113 in-duces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activa-tion of cyclooxygenase by nitric oxide. Biochemistry (1993) 32:13767–13770.
  • SAUTEBIN L, IALENTI A, IANARO A, DI ROSA M: Modula-tion by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. PharmacoL (1995) 114:323–328.
  • SAUTEBIN L, DI ROSA M: Nitric oxide modulates prosta-cyclin biosynthesis in the lung of endotoxin-treated rats. Dir. J. PharmacoL (1994) 262:193–196.
  • CLOSA D, HOTTER G, PRATS N et al.: Prostanoid genera-tion in early stages of acute pancreatis: a role for nitric oxide. Inflammation (1994) 18:469–480.
  • BECKMAN JS, CHEN J, CONGER K: The importance of su-peroxide in nitric oxide-dependent cerebral ischemic injury. In: Nitric Oxide and Oxidative Stress. (1993) 3:25–30.
  • RUBBO H, RADI R, TRUJILLO M et al.: Nitric oxide regula-tion of superoxide and peroxynitrite-dependent lipid peroxidation. J. BioL Chem. (1994) 269:26066–26070.
  • WINK DA, INGEBORG H, KRISHNA MC eta/.: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci, USA (1993) 90:9813–9815.
  • LIPTON SA, CHOI Y-B, PAN Z-H et al.: A redox-based mechanism for the neuroprotective and neurode-structive effects of nitric oxide and related nitroso-compounds. Nature (1994) 364:626–630.
  • RADI R, BECKMAN JS, BUSH KM, FREEMAN BA: Peroxyni-trite induced membrane lipid peroxidation: the cyto-toxic potential of superoxide and nitric oxide. Arch. Biochem, Biophys, (1991) 288:481–483.
  • RADI R, RODRIGUEZ M, CASTRO L, TELLERI R: Inhibition of mitochondrial electron transport. Arch. Biochem, Biophys, (1994) 89:308–312.
  • HAUSLADEN A, FRIDOVICH I: Superoxide and per-oxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. (1994) 269:29405–29407.
  • CASTRO L, RODRIGUEZ M, RADI R: Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. (1994) 269:29409–29410.
  • GROVES JT, MARLA S: Peroxynitrite-induced DNA strand scission mediated by a manganese porphyrin. J. Am. Chem. Soc. (1995) 117:9578–9582.
  • SZABO C, SALZMAN AL, ISCHIROPOULOS H: Endotoxin triggers the expression of an inducible isoform of ni-tric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. (1995) 363:235–340.
  • KAUR H, HALLIWELL B Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheu-matoid patients. FEBS Lett. (1995) 350:9–13.
  • RACHMILEWITZ D, STAMLER JS, KARMELI F et al.: Peroxynitrite-induced rat colitis: a new model of colo-nic inflammation. Gastroenterology (1993) 105:1681–1687.
  • OURY TD, PIANTADOS CA, CRAPO JD: Cold-induced brain oedema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. (1993) 268:15394–15399.
  • MEDELE RJ, STUMMER W, REULEN HJ, STEIGER HJ: Evi-dence for peroxidative damage by nitric oxide in ex-perimental chronic cerebral vasospasm. NeuroL Res. (1996) 18:277–280.
  • MANNICK EE, BRAVO LE, ZARAMA G et al.: Inducible ni-tric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. (1996) 56:3238–3240.
  • AKAIKE T, NOGUCHI Y, IJIRI S et al.: Pathogenesis of in-fluenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl Acad. Sci, USA (1996) 93:2448–2450.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.